Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Frode Lerang, René Holst, Magne Henriksen, Henrik Wåhlberg & Lars-Petter Jelsness-Jørgensen. (2022) Antitumour necrosis factor alpha treatment in Crohn’s disease: long-term efficacy, side effects and need for surgery. Scandinavian Journal of Gastroenterology 57:8, pages 921-929.
Read now
Read now
Ji Min Lee, Yoon Jae Kim, Kang-Moon Lee, Hyuk Yoon, Bo-In Lee, Dae Bum Kim & Donghoon Kang. (2018) Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 53:10-11, pages 1280-1285.
Read now
Read now
Articles from other publishers (16)
Darragh Storan, Edel McDermott, Jenny Moloney, Lisa Keenan, Roisin Stack, Juliette Sheridan, Glen Doherty, Garret Cullen, Louise McHugh & Hugh E Mulcahy. (2024) Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation. Frontline Gastroenterology 15:2, pages 130-136.
Crossref
Crossref
Kunio Asonuma, Keiji Ozeki, Hajime Yamazaki, Shinji Okabayashi, Soh Okano, Ryo Ozaki, Nobuaki Nishimata, Hiroki Kiyohara, Naoki Ichinari, Taku Kobayashi, Masahiro Yamada, Mao Matsubayashi, Yoko Yokoyama, Shoko Arimitsu, Junji Umeno, Yoshinori Munetomo, Akira Andoh & Shinichiro Shinzaki. (2023) Immunomodulators after the discontinuation of anti‐tumor necrosis factor‐alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study. Journal of Gastroenterology and Hepatology 39:1, pages 66-73.
Crossref
Crossref
Alex Arenas, María José Moreta, Ingrid Ordás, Agnès Fernández-Clotet, Berta Caballol, Marta Gallego, Alejandro Vara, Rebeca Barastegui, Angel Giner, Cristina Prieto, Maria Carme Masamunt, Roberto Candia & Elena Ricart. (2023) De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice. Gastroenterología y Hepatología.
Crossref
Crossref
Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihiro Fujiya, Kitaro Futami, Keisuke Hata, Fumihito Hirai, Sakiko Hiraoka, Tadakazu Hisamatsu, Ryota Hokari, Shunji Ishihara, Soichiro Ishihara, Michio Itabashi, Yoichi Kakuta, Jun Kato, Shingo Kato, Takehiko Katsurada, Kazuya Kitamura, Kiyonori Kobayashi, Taku Kobayashi, Kazutaka Koganei, Atsuo Maemoto, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Matsuoka, Minoru Matsuura, Satoshi Motoya, Masakazu Nagahori, Makoto Naganuma, Yuji Naito, Shiro Nakamura, Hiroshi Nakase, Haruhiko Ogata, Kazuichi Okazaki, Hirotake Sakuraba, Masayuki Saruta, Shinichiro Shinzaki, Ken Sugimoto, Akira Sugita, Yasuo Suzuki, Kenichi Takahashi, Tomohisa Takagi, Kento Takenaka, Ken Takeuchi, Kiichiro Tsuchiya, Tomoyuki Tsujikawa, Motoi Uchino, Fumiaki Ueno, Kenji Watanabe, Mamoru Watanabe, Takayuki Yamamoto, Kaoru Yokoyama, Atsushi Yoshida & Naoki Yoshimura. (2023) Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021. Journal of Gastroenterology 58:4, pages 313-345.
Crossref
Crossref
Cong Dai, Yi-Nuo Wang, Wen-Ning Tian, Yu-Hong Huang & Min Jiang. (2023) Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Sine Buhl, Casper Steenholdt, Jørn Brynskov, Katrine Risager Christensen, Maria Dorn-Rasmussen, Ole Østergaard Thomsen, Klaus Bendtzen, Tobias Wirenfeldt Klausen, Jens Frederik Dahlerup, Niels Thorsgaard, Jørgen Jahnsen, Akbar Molazahi, Natalia Pedersen, Jens Kjeldsen, Sven Almer, Eva Efsen Dahl, Ida Vind, Annett Gerhardt Cannon, Jan Marsal, Taina Sipponen, Jørgen Steen Agnholt, Hendrika Adriana Linda Kievit, Synnøve Louise Aure, Lars Martinsen, Svetlana Meisner, Jane Møller Hansen & Mark Andrew Ainsworth. (2022) Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease. NEJM Evidence 1:8.
Crossref
Crossref
Uday N. Shivaji, Alina Bazarova, Tamsin Critchlow, Samuel C. L. Smith, Olga Maria Nardone, Melanie Love, Joanne Davis, Subrata Ghosh & Marietta Iacucci. (2020) Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy. Therapeutic Advances in Gastroenterology 13, pages 175628482098121.
Crossref
Crossref
Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Alaa El-Hussuna, Pierre Ellul, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Fernando Gomollon, Marien González-Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos Katsanos, Uri Kopylov, Eduards Krustins, Theodore Lytras, Christian Maaser, Fernando Magro, John Kenneth Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, Joao Sabino, Edoardo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora & Gionata Fiorino. (2020) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. Journal of Crohn's and Colitis 14:1, pages 4-22.
Crossref
Crossref
Thomas P Chapman, Catarina Frias Gomes, Edouard Louis, Jean-Frédéric Colombel & Jack Satsangi. (2020) De-escalation of immunomodulator and biological therapy in inflammatory bowel disease. The Lancet Gastroenterology & Hepatology 5:1, pages 63-79.
Crossref
Crossref
E. Yu. Chashkova, N. S. Korotayeva, E. E. Kunetsova, V. G. Gorokhova & E. V. Soboleva. (2019) Assessment of the State of Cell Membranes against the Background of Prolonged Use of Anticytokine Therapy in Patients with Ulcerative Colitis. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 4:5, pages 84-90.
Crossref
Crossref
Abhinav Vasudevan, Peter R Gibson & Daniel R Van Langenberg. (2019) Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 25:9, pages 1462-1473.
Crossref
Crossref
Fabiana Castiglione, Nicola Imperatore, Anna Testa, Giovanni Domenico De Palma, Olga Maria Nardone, Lucienne Pellegrini, Nicola Caporaso & Antonio Rispo. (2019) One‐year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. Alimentary Pharmacology & Therapeutics 49:8, pages 1026-1039.
Crossref
Crossref
María Chaparro, María G. Donday, Manuel Barreiro-de Acosta, Eugeni Domènech, María Esteve, Valle García-Sánchez, Pilar Nos, Julián Panés, Concepción Martínez, Javier P. Gisbert, F. Abad, M. Aguas Peris, E. Agüero Tejado, C. Alba, M. Albert, H. Alemán, A. Algaba, I. Alonso Abreu, M.P. Amador, M. Amat, T. Angueira, C. Arajol, L. Arias-González, A. Arrondo Velasco, M. Baldán, B. Bardán García, A. Bargalló García, M. Barreiro de Acosta, J. Barrio Andrés, G. Bastida Paz, I. Bastón Rey, L. Batista, M. Bellver Martínez, B. Beltrán Niclós, J.M. Benítez, Y. Ber Nieto, F. Bermejo, D. Bernardo, I. Blázquez Gómez, A. Bouhmidi Assakali, D. Busquets Casals, J.L. Cabriada Nuño, X. Calvet Calvo, M.V. Calvo Hernández, M. Calvo, B. Camps, A.Y. Carbajo, G. Cardona Peitx, T. Caro-Patón, M. Carrillo Palau, S. Carrión Bolorino, M.J. Casanova, J.A. Casellas Valdé, A. Castaño García, B. Castro Senosiain, D. Ceballos, E. Cerrillo, S. Chacón Martínez, F. Consuelo Cañete Pizarro, M.L. de Castro Parga, M. de Miguel, R. de Francisco García, M.D. de la Cruz Ramírez, J. del Hoyo Francisco, P. Delgado Guillena, T. Desongles Corrales, A. Echarri Piudo, E. Espino Paisan, M. Espona Quer, A. Fernández Pordomingo, J.L. Fernández Forcelledo, S. Fernández-Tomé, R. Ferreiro Iglesias, I. Ferrer Bradley, A. Ferrer, A. Figueroa, M. Gallach Montero, P. García Iglesias, C. García García-Lezcún, L. García Ramírez, M.J. García García, O. García-Bosh, A. Garre, T. Giménez Poderós, L. Gómez Irwin, B. Gómez Pastrana, E. Gómez Delgado, Y. González Lama, Á. Gracia García, B. Gracia García, J. Guardiola, I. Guerra, E. Guerra, V. Guillot, S. Gustmancher Saiz, A. Gutiérrez Casbas, V. Hernández Ramírez, M.M. Hernando Verdugo, B. Hernández Muniesa, R. Hernanz Chaves, J.M. Herrera Justiniano, J Hinojosa del Val, S Ibáñez Feijoo, M Iborra Colomino, E Iglesias Flores, E. Izquierdo García, M J Sampedro González, A J. Lucendo, N Jiménez García, E. Leo Carnerero, I. Loizaga Díaz, A López de Torre Querejazu, P López Sánchez, J Luis Parras, M Maia Boscá, M Mañosa, S Marín Pedrosa, A Marín, Á Marinero, I Marín-Jiménez, L Márquez Mosquera, JL Márquez Galán, E Martín Arranz, MD Martín Arranz, J Martínez Cadilla, JM Martínez Sesmero, B Martínez Sánchez, V Matallana, MI Mateos Hernández, AG McNicholl, R Mejuto Fernández, L Melcarne, L Menchén, J Méndez-Castrillón Rodríguez, O Merino Ochoa, M Mínguez, G Molas Ferrer, M Montoro Huguet, A Montserrat Torres, F Mora, I Moraleja Yudego, VJ Morales Alvarado, L Morales Martínez, A Morell, C Motos García, F Muñoz Alonso, MC Muñoz Villafranca, JE Muñoz, A Mur, Ó Nantes, P Navarro, M Navarro- Llavat, P Nos Mateu, A Núñez Alonso, A Núñez Ortiz, D Olivares, V Ollero Pena, J Orobitg, L Ortega, J Ortiz de Zárate, H Pallarés Manrique, A Paradela Carreiro, L Peral Ballester, S Pereira Bueno, I Pérez Martínez, JR Pineda Mariño, C Piñero Pérez, A Planas Giner, MR Plaza Santos, Á Ponferrada Díaz, J Poza Cardón, V Prieto Vicente, L Puchades, L Ramos López, S Redondo, S Riestra Menéndez, M Rivero Tirado, I Rodríguez Lago, C Rodríguez Gutiérrez, E Rodríguez, S Romero Izquierdo, S Rubio Iturria, MB Ruiz Antorán, A Ruiz, LF Salazar, A Sánchez Ulayar, E Sánchez Gómez, C Sánchez, C Sangrador, K Serra, K Spicakova, C Suárez Ferrer, A Talavera Fabuel, C Taxonera, M Tordera, E Torrella Cortés, J Tosca, C Trigo Salado, F Uriarte Estefanía, M Van Domselaar, JM Vázquez Morón, P Ventura López, M Vera, M Vicuña Arregui, A Villoria Ferrer, T Virgós Aller & D Yáñez Feria. (2019) Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial. Therapeutic Advances in Gastroenterology 12, pages 175628481987420.
Crossref
Crossref
Loris Lopetuso, Viviana Gerardi, Valerio Papa, Franco Scaldaferri, Gian Rapaccini, Antonio Gasbarrini & Alfredo Papa. (2017) Can We Predict the Efficacy of Anti-TNF-α Agents?. International Journal of Molecular Sciences 18:9, pages 1973.
Crossref
Crossref
Giovanni C Actis. (2016) Biologics for Ulcerative Colitis: Status of the Art and General Considerations. Annals of Colorectal Research 5:1.
Crossref
Crossref
Giovanni C Actis. (2016) Biologics for Ulcerative Colitis: Status of the Art and General Considerations. Annals of Colorectal Research Inpress:Inpress.
Crossref
Crossref